The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer
Eileen E. Parkes(Nuffield Orthopaedic Centre), N.M Buckley(Queen's University Belfast), SM Phyu(University of Oxford), Elaine S. Gilmore(Queen's University Belfast), FA Sidi(Queen's University Belfast), Manuel Salto‐Tellez(Queen's University Belfast), Stephen McQuaid(Queen's University Belfast), SG Craig(Queen's University Belfast), Victoria Bingham(Quadram Institute), MP Humphries(Queen's University Belfast), Jessica A. Miller, Cathy Graham(Queen's University Belfast), S.F. Bakhoum(Memorial Sloan Kettering Cancer Center), R. D. Kennedy(Queen's University Belfast), Daryl Griffin(Queen's University Belfast)
Cited by 1
Related Papers
QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809
Hydrogen sulfide is a novel mediator of lipopolysaccharide‐induced inflammation in the mouse
|The FASEB Journal|2005|766
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
|JNCI Journal of the National Cancer Institute|2016|457
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis
|Cancer Discovery|2020|293